𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedules

✍ Scribed by S. Agladioglu; U. Beyazova; A. D. Camurdan; F. Sahin; A. Atak


Book ID
107705865
Publisher
Springer-Verlag
Year
2010
Tongue
English
Weight
203 KB
Volume
38
Category
Article
ISSN
0300-8126

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Safety and immunogenicity of a recombina
✍ E. Dandolos; A. Roumeliotou-Karayannis; S. C. Richardson; Prof. G. Papaevangelou πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 340 KB

A hepatitis B vaccine produced in yeast by recombinant DNA technology was evaluated using 5-micrograms and 10-micrograms doses in a randomized trial lasting 7 months in 110 male armed forces recruits aged 17-19 years. Results were compared to those of an identical trial of a plasma-derived vaccine.

Immunogenicity of 20 ΞΌg of recombinant D
✍ R. Del Canho; P. M. Grosheide; M. Voogd; W. M. Huisman; R. A. Heijtink; Dr. S. W πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 558 KB

## Abstract The immunogenicity of a full dose (20 ΞΌg) of recombinant DNA yeast‐derived hepatitis B vaccine (Engerix‐B) was assessed in healthy neonates in order to compare three candidate vaccination schemes. After randomization 162 newborns of hepatitis B surface antigen (HBsAg) negative mothers e